Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
CancerTestRequisitionForm CollectionDate(mm/dd/yyyy):____________________________ OfficeUseOnly: DateReceived:____________________________________________________________ SpecimenType:!Buccal!Blood(2mLinlavendertoptube) PATIENTINFORMATION !Saliva!Other_________________________________ _________________________________________________________________________________________________________________________ FirstName MiddleName LastName ______________________________________________________________________________________________________________________________________________________________________________________ StreetAddress ______________________________________________________________________________________________________________________________________________________________________________________ City State ZipCode HomePhone:________________________________________________________ Gender: ☐Male☐FemaleDOB(mm/dd/yyyy):________________________________ Ancestry:☐AfricanAmerican☐Caucasian☐Hispanic☐European☐MiddleEastern☐Asian☐Ashkenazi-Jewish☐Central/SouthAmerican ☐Other_______________________________________________________ ORDERINGACCOUNTINFORMATION _________________________________________________________________________________________________________________________ PracticeName ProviderName ProviderNPI# ______________________________________________________________________________________________________________________________________________________________________________________ StreetAddress ______________________________________________________________________________________________________________________________________________________________________________________ City State ZipCode OfficePhone:__________________________________________OfficeFax:__________________________________________Email:_____________________________________________________________ AdditionalPhysicianorGeneticCounselortobecopied:Name:__________________________________________________________________Fax#:____________________________________ PHYSICIANAUTHORIZATION Thistestismedicallynecessaryfortheriskassessment,diagnosisordetectionofadisease,illness,impairment,symptom,syndromeordisorder.Theresults willdeterminemypatient’smedicalmanagementandtreatmentdecisions.Bymysignaturebelow,IindicatethatIamthereferringphysicianorauthorized healthcareprovider.Ihaveexplainedthepurposeofthetest.Thepatienthasbeengiventheopportunitytoaskquestionsand/orseekgeneticcounseling.The patienthasvoluntarilydecidedtohavethetestperformedbymyGenomics. __________________________________________________________________________________________________________ MedicalProfessionalSignature(required) Date(mm/dd/yyyy) PATIENTAUTHORIZATION Signhereorontheconsentdocument. IhavereadtheInformedConsentdocumentandgivemypermissiontomyGenomicstoperformgenetictestingasdescribed.Ialsogivepermissionformy specimenandclinicalinformationtobeusedinde-identifiedstudiesatmyGenomicstoimprovegenetictestingandforpublication,ifappropriate.Mynameor otherpersonalidentifyinginformationwillnotbeusedinorlinkedtotheresultsofanystudiesandpublications.IalsogivemyGenomicspermissiontoinform meinthefutureaboutresearchopportunities,includingtreatmentsfortheconditioninmyfamily. ! Checkthisboxifyouwanttooptoutofresearchstudies.!Checkthisboxifyoudonotwishtobecontacted. ! CheckthisboxifyouareaNYresidentandgivemyGenomicspermissiontoretainanyremainingsamplelongerthan60daysafterthecompletionoftesting. ________________________________________________________________________________________ Patient/GuardianSignature Date(mm/dd/yyyy) BILLINGINFORMATION BillingType: !CommercialInsurance !Medicare!Medicaid Priorauthorization#:_______________________________________________________________________ Pleasecompletethefollowingandattachacopyofthefrontandbackofthepatient’sinsurancecard(includesecondarywhenapplicable). _______________________________________________________________________________________________ /___________________________________________________________________________________________________________ PrimaryInsuranceCarrier ID# Group# SecondaryInsuranceCarrier ID# Group _______________________________________________________________________________________________/___________________________________________________________________________________________________________ NameofInsuredPerson RelationshiptoPatientNameofInsuredPerson RelationshiptoPatient _______________________________________________________________________________________________ /___________________________________________________________________________________________________________ InsuredDateofBirth Startdateofcoverage InsuredDateofBirth Startdateofcoverage CLIA#11D2084528 11535ParkWoodsCircle,SuiteE;Alpharetta,GA30005 1-855-647-4363 www.mygenomics.com MGV101/REV 09-16 PatientName:____________________________________ DateofBirth:________________________ PERSONALHISTORYOFCANCER(S)ORTUMOR(S) ☐ BreastCancer AgeofDiagnosis:______________ ☐ NoPersonalHistoryofCancer/Tumor ☐ OvarianCancer AgeofDiagnosis:__________________ ☐ER☐PR☐HER2☐TripleNegative☐Bilateral ☐TwoPrimaries☐InvasiveDuctal☐InvasiveLobular ☐DCIS☐LCIS☐Other:____________________________________________ ☐Serous☐Mucinous☐Endometrioid ☐ ClearCell ☐LMP/Borderline ☐Other:__________________________________________________________________ ☐ EndometrialCancerAgeofDiagnosis:______________ ☐ PancreaticCancerAgeofDiagnosis:_________________ ☐ ColorectalCancerAgeofDiagnosis:______________ ☐ Melanoma ☐Serous☐Mucinous☐Endometrioid☐ClearCell ☐Sarcoma ☐Other:____________________________________________________________ ☐Adenocarcinoma☐IPMN ☐Neuroendocrine ☐Other:__________________________________________________________________ Location:☐Right☐Left☐Transverse☐Rectum ☐ ProstateCancer AgeofDiagnosis:______________ ☐Invasive☐In-Situ ☐ Polyp(s) ☐GleasonScore:__________________________________________________ ☐Other:___________________________________________________________ ☐ GastricCancer/TumorAgeofDiagnosis:______________ ☐ BrainCancerAgeofDiagnosis:___________________ Pathology:_____________________________________________________________ ☐ RenalCancer ☐ThyroidPathology/Diagnosis:______________________________ ☐Pheochromocytoma(PCC) ☐Paraganglioma(PGL)Location:_______________________________ ☐ HematologicDisease AgeofFirstPolyp:_________________ ☐Adenomatous–total#:______________________________________________ ☐Other–Pathology:_______________________________Total#:__________ Pathology:________________________________________________________ ☐ EndocrineCancer/DiseaseAgeofDiagnosis:______________ AgeofDiagnosis:__________________ AgeofDiagnosis:__________________ ☐Bilateral☐ClearCell ☐PapillaryType(IorII):______________________________________________ ☐TransitionalCell☐Other__________________________________________ AgeofDiagnosis:_______________ ☐ OtherCancer/Tumor________________________________________ Diagnosis:______________________________________________________________ Status:☐Active/ResidualDisease☐Remission AgeofDiagnosis:______________________________________________ FAMILYHISTORYOFCANCER(S)ORTUMOR(S) ☐ NoKnownFamilyHistoryofCancer(s)orTumor(s)☐PedigreeAttached☐Adopted Pleaseincludeallclinicaldetails,suchasbilateral,pathology(includingtriplenegativebreastcancer),premenopausalbreastcancer, andGleasonscoreforprostatecancer,ifavailable. Relationship Maternal Paternal Cancer/TumorSite AgeatDiagnosis ________________________________________ ☐ ☐ __________________________________________________________ ____________________ ________________________________________ ☐ ☐ __________________________________________________________ ____________________ ________________________________________ ☐ ☐ __________________________________________________________ ____________________ ________________________________________ ☐ ☐ __________________________________________________________ ____________________ PERSONALGENETICTESTINGHISTORY(Pleaseincludeallcopiesoftestsandrelatedmedicalrecords.) ☐ NoPersonalHistoryofGeneticTesting ☐ Gene(s)Tested:_______________☐Positive☐Negative/_______________☐Positive☐Negative/_______________☐Positive☐Negative _______________☐Positive☐Negative/_______________☐Positive☐Negative/_______________☐Positive☐Negative PREVIOUSFAMILIALGENETICTESTING ☐ NoFamilyHistoryofGeneticTesting☐RelativeTested:______________________________Gene(s)Tested:________________________ ☐Positive☐Negative☐VUS(VariationofUnknownSignificance) CLIA#11D2084528 11535ParkWoodsCircle,SuiteE;Alpharetta,GA30005 1-855-647-4363 www.mygenomics.com MGV101/REV 09-16 PatientName:____________________________________ DateofBirth:________________________ HC0001 AdenomatousPolyposisPanel (2Genes) APC,MUTYH ApplicableICD-10codesmayinclude: D12.0 D12.1 D12.2 D12.3 D12.4 D12.5 D12.6 D12.7 D12.8 D37.4 D37.5 D48.1 D49.0 Z83.71 Z86.010 Z87.39 OtherICD-10codes:_____________________________________________________________________________________________ HC0002 BreastBasicCancerPanel (2genes) BRCA1,BRCA2 ApplicableICD-10codesmayinclude: C50.929 D05.00 D05.90 D07.30 Z15.01 Z15.02 Z80.3 Z80.41 Z80.42 Z84.81 Z85.3 Z85.43 OtherICD-10codes:__________________________ HC0003 BreastCancerHigh/ModRiskPanel (8genes) ATM,BRCA1,BRCA2,CDH1,CHEK2,PALB2,PTEN,TP53 ApplicableICD-10codesmayinclude: C50.929 D05.00 D05.90 D07.30 Z15.01 Z15.02 Z80.3 Z80.41 Z80.42 Z84.81 Z85.3 Z85.43 OtherICD-10codes:__________________________ HC0004 BreastCancerPanel (44Genes) ACVR1B,AKT1,ATM,BAP1,BRCA1,BRCA2,CBFB,CDH1,CDKN2A,EGFR,EP300,ERBB2, ERBB3,ESR1,EXOC2,EXT2,FBXO32,FGFR1,FGFR2,GATA3,IRAK4,ITCH,KMT2C, MAP2K4,MAP3K1,MDM2,MUC16,MYC,NCOR1,NEK2,PBRM1,PCGF2,PIK3CA,PIK3R1, PPM1L,PTEN,PTGFR,RB1,RET,SEPT9,TP53,TRAF5,WEE1,ZBED4, ApplicableICD-10codesmayinclude: C50.929 D05.00 D05.90 D07.30 Z15.01 Z15.02 Z80.3 Z80.41 Z80.42 Z84.81 Z85.3 Z85.43 OtherICD-10codes:__________________________ HC0005 Breast/OvarianCancerPanel (21Genes) ATM,BARD1,BRCA1,BRCA2,BRIP1,CDH1,CHEK2,EPCAM,FANCC,MLH1,MSH2,MSH6, NBN,PALB2,PMS2,PTEN,RAD51C,RAD51D,STK11,XRCC2,TP53 ApplicableICD-10codesmayinclude: C50.929 D05.00 D05.90 D07.30 Z15.01 Z15.02 Z80.3 Z80.41 Z80.42 Z84.81 Z85.3 Z85.43 OtherICD-10codes:__________________________ HC0006 OvarianCancerPanel (32Genes) AKT1,ARID1A,BRAF,BRCA1,BRCA2,CBLC,CCNE1,CDK12,CDKN2A,CSMD3,CTNNB1, CUBN,EGFR,ERBB2,FAT3,GABRA6,KIT,KRAS,KREMEN1,MAS1L,MLH1,MSH2,NF1, NRAS,PDGFRA,PIK3CA,PIK3R1,PPP2R1A,PTEN,RB1,TP53,USP16 ApplicableICD-10codesmayinclude: C50.929 D05.00 D05.90 D07.30 Z15.01 Z15.02 Z80.3 Z80.41 Z80.42 Z84.81 Z85.3 Z85.43 OtherICD-10codes:__________________________ HC0007 ColorectalCancerPanel (38Genes) ACVR1B,AKT1,APC,ATM,ATP6VOD2,BAX,BRAF,CASP8,CDC27,CTNNB1,DCC,DMD, EP300,ERBB2,FBXW7,FZD3,GPC6,KRAS,MAP2K4,MAP7,MIER3,MLH1,MSH2,MSH3, MSH6,MYO1B,NRAS,PIK3CA,PIK3R1,PTPN12,SLC9A9,SMAD2,SMAD4,TCERG1, TCF7L2,TGFBR2,TP53,WBSCR17 ApplicableICD-10codesmayinclude: C18.9 C19 C20 C21.0 D01.0 D01.1 D01.2 D01.3 D01.40 D01.7 D01.9 K63.5 Z80.0 Z83.71 Z83.79 Z84.81 Z85.00 Z86.010OtherICD-10codes:________________________________________________________________________________ HC0008 EndocrineNeoplasiaPanel (7Genes) CDC73,HRAS,MEN1,PRKAR1A,PTEN,RET,VHL ApplicableICD-10codesmayinclude: C70.0 C70.1 C70.9 C75.0 C75.1 D09.3 D17.9 D42.9 E21.5 E23.7 Z15.81 Z83.41 Z83.49 Z84.81 Z85.850 Z85.858 OtherICD-10Codes:__________________________________________________________________________________________ HC0009 EndometrialCancerPanel (12Genes) BRCA1,BRCA2,CHEK2,EPCAM,MLH1,MSH2, MSH6,MUTYH,PMS2,POLD1,PTEN,TP53 ApplicableICD-10codesmayinclude: N85.0 N85.00 C54.1 C54.2 Z15.04 OtherICD-10codes:__________________________________________________________________________________________ HC0010 GastricCancerPanel (29Genes) APC,ATP4A,BAI3,BRCA2,CCNE1,CDH1,CTNNB1,DCC,ERBB2,FBXW7,FGFR2,GPR78, LPAR2,PRP1B,LRRK2,MET,MYC,NOTCH1,PIK3CA,PRKDC,RET,S1PR2,SPEG,SSTR1, STK11,TP53,TRIO,TRRAP,WNK2 ApplicableICD-10codesmayinclude: C15.9 C16.9 C17.9 D00.1 D00.2 D05.90 Z80.0 Z84.81 Z85.00 OtherICD-10codes:____________________________________________________________________ HC0011 Li-FraumeniSyndromeCancerPanel (2Genes) CHEK2,TP53 ApplicableICD-10codesmayinclude: C41.9 C49.9 C50.919 C50.929 C71.9 C74.90 D05.00 D05.10 D05.90 D09.8 D43.2 D43.4 Z85.830 OtherICD-10codes:__________________________________________________________________________________________ CLIA#11D2084528 11535ParkWoodsCircle,SuiteE;Alpharetta,GA30005 1-855-647-4363 www.mygenomics.com MGV101/REV 09-16 HC0012 LiverCancerPanel (33Genes) ALB, AMPH, APC, ARID1A, ARID2, ATM, AXIN1, BAZ2B, BRAF, CCDC178, CDKN2A, CSMD3, CTNNB1, DSE, ELMO1, ERBB2, ERRFI1, GXYLT1, IGF2R, IGSF10, KEAP1, KRAS, MET, NHF1A, OTOP1, PIK3CA, SAMD9L, TP53, UBR3, USP25, WWP1, ZIC3, ZNF226 ApplicableICD-10Codesmayinclude: C22.8 E83.11 OtherICD-10codes:_________________________ HC0013 LungCancerPanel (45Genes) AKT1,ALK,APC,ATM,BAI3,BAP1,BRAF,CDKN2A,EGFR,EPHA5,ERBB2,ERBB4,FBXW7,FGFR1, FGFR2,GRM8,KDR,KEAP1,KIT,KMT2D,KRAS,LRP1B,MDM2,MET,MLH1,MUC16,MYC,NF1, NFE2L2,NOTCH1,PDGFRA,PIK3CA,PIK3CG,PKHD1,PTEN,RARB,RB1,RET,ROS1,RUNX1T1, SMAD4,SMARCA4,SOX2,STK11,TP53+in/del ApplicableICD-10codesmayinclude: D38.1 C34.80 C34.90 C34.12 C34.81 C34.82 Z85.118 Z80.1 OtherICD-10codes:___________________________________________________________________ HC0014 Lynch/ColorectalCancerPanel (8Genes) APC, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN ApplicableICD-10codesmayinclude: C18.9 C19 C20 C21.0 D01.0 D01.1 D01.2 D01.3 D01.40 D01.7 D01.9 K63.5 Z80.0 Z83.71 Z83.79 Z84.81 Z85.00 Z86.010OtherICD-10codes:________________________________________________________________________________ HC0015 MelanomaCancer Panel(13Genes) BAP1, BRCA2, CDK4, CDKN2A, MC1R, MITF, NF1, PTEN, RB1, TP53, VH1, XPA, XPC ApplicableICD-10codesmayinclude: C25.9 C43.9 D01.7 D01.9 D03.9 D04.9 Z80.0 Z80.8 Z84.81 Z85.820 OtherICD-10codes:________________________________________________________ HC0016 PachyonychiaCogenita Panel(9Genes) AAGAB, DSG1, GJB6, KRT6A, KRT6B, KRT6C, KRT16, KRT17, TRPV3 ApplicableICD-10codesmayinclude: Q84.3 Q84.4 Q84.5 Q84.6 OtherICD-10codes:_________________________________________________________________________________________ HC0017 PancreaticCancerPanel (16Genes) APC,ATM,BRCA1,BRCA2,CDK4,CDKN2A,EPCAM,MLH1,MSH2,MSH6,PALB2,PMS2,STK11, TP53,VHL,XRCC2 ApplicableICD-10codesmayinclude: C25.9 C80.1 D01.7 D01.9 Z80.0 Z84.81 Z85.07 OtherICD-10codes:_________________________________________________________________________________________ HC0018 ProstateCancerPanel (32Genes) AKAP9,APC,AR,CDK12,CDKN1B,CDKN2A,GLI1,IKZF4,KDM4B,KLF6,KMT2D,MED12,MYC, NCOA2,NIPA2,NKX3-1,NRCAM,OR5L1,PDZRN3,PIK3CA,PTEN,RB1,SCN11A,SPOP,SYNE3, TBX20,TFG,THSD7B,TP53,ZFHX3,ZNF473,ZNF595 ApplicableICD-10codesmayinclude: D07.5 R97.2 Z15.03 Z80.41 Z80.42 Z84.81 Z85.46 OtherICD-10codes:_________________________________________________________________________________________ HC0019 RenalCancer Panel(19genes) BAP1,EPCAM,FH,FLCN,MET,MITF,MLH1,MSH2,MSH6,PMS2,PTEN,SDHA, SDHB,SDHC,SDHD, TP53,TSC1,TSC2,VHL ApplicableICD-10codesmayinclude: C64.9 C65.1 C65.2 C65.9 V16.51 OtherICD-10codes:________________________________________________________________________________________ HC0020 TruSight Cancer Predisposition panel (94 Genes+284SNPs) AIP,ALK,APC,ATM,BAP1,BLM,BMPR1A,BRCA1,BRCA2,BRIP1,BUB1B,CDC73,CDH1,CDK4, CDKN1C,CDKN2A,CEBPA,CEP57,CHEK2,CYLD,DDB2,DICER1,DIS3L2,EGFR,EPCAM,ERCC2, ERCC3,ERCC4,ERCC5,EXT1,EXT2,EZH2,FANCA,FANCB,FANCC,FANCD2,FANCE,FANCF,FANCG, FANCI,FANCL,FANCM,FH,FLCN,GATA2,GPC3,HNF1A,HRAS,KIT,MAX,MEN1,MET,MLH1,MSH2, MSH6,MUTYH,NBN,NF1,NF2,NSD1,PALB2,PHOX2B,PMS1,PMS2,PRF1,PRKAR1A,PTCH1,PTEN, RAD51C,RAD51D,RB1,RECQL4,RET,RHBDF2,RUNX1,SBDS,SDHAF2,SDHB,SDHC,SDHD,SLX4, SMAD4,SMARCB1,STK11,SUFU,TMEM127,TP53,TSC1,TSC2,VHL,WRN,WT1,XPA&XPC ICD-10codes:________________________________________________________________________________________________ HC0021 HereditarySingleGeneorGeneSet RequestedGene(s):____________________________________________________________________________________________ ICD-10codes:________________________________________________________________________________________________ Requested Gene(s): ____________________________________________________________________________________________ HC0022 VariantTesting(previously identifiedfamilialmutation) ICD-10codes: ________________________________________________________________________________________________ RequestedGene(s):____________________________________________________________________________________________ ICD-10codes:________________________________________________________________________________________________ HC0023 FocusedExomeTesting (5,500genes) ICD-10codes:________________________________________________________________________________________________ HC0024 WholeExomeSequencingTRIO (22,000genes) ICD-10codes:________________________________________________________________________________________________ HC0025 WholeExomeSequencingPROBAND ICD-10codes:________________________________________________________________________________________________ HC0026 WholeExomeSequencingAdditional FamilyMember ICD-10codes:________________________________________________________________________________________________ HC0027 WholeGenome ICD-10codes:________________________________________________________________________________________________ CLIA#11D2084528 11535ParkWoodsCircle,SuiteE;Alpharetta,GA30005 1-855-647-4363 www.mygenomics.com MGV101/REV 09-16 InformedConsentandAuthorizationForm Iunderstandthatmyhealthcareproviderhasorderedthefollowinggenetictestingfor:☐Me☐MyChild Signature:__________________________________________________________ Whatisgenetictesting? Genetictestingisananalysisofaperson’sgeneticmakeup.Everyoneisbornwithadistinctsetofgenesthatisuniqueto them. These genes provide instructions for the body to grow and develop. Sometimes a person’s genes may be altered during formation and could lead to a specific syndrome, disease or birth defect. Depending on the type of genetic test ordered,ageneticconditionorseveralconditionscouldbedetectedthatincreaseyourriskofasyndrome,diseaseand/or defect. Your provider or a genetic counselor should inform you about these conditions for which you are being offered testing.Youmayalsoneedtofollowupwithageneticcounselororyourprovidertodiscusstheresultsafterthetesting. Whatisthepurposeofgenetictesting? Thegenetictestisconsideredapredictivetestifitisperformedtoidentifywhetherapatientisatanincreasedriskof developingahereditarydefectordiseasebutdoesnotdetermineforcertainthatadefectordiseasewilloccur.Ifagenetic testisbeingperformedafteradefectordiseasehasbeendiagnosedandthetestconfirmsthecausetobeinrelationtothe gene(s),itisconsideredadiagnosticorconfirmatorytest. Howisagenetictestperformed? Genetictestsareusuallyperformedbyeitherbloodtestingorobtainingtissueorcheekcellsamples.Thesesamples containwhitebloodcellsthatcontainyourDNA,RNAandimportantproteins.Whentestingduringpregnancy,chorionic villus,amnioticfluidorasampleofthemother’sbloodcanbeused. Whatarethelimitationsofgenetictesting? Agenetictestmayprovideveryimportantinformationaboutyourhealthbuttherearelimitations: • Performingthecorrecttest:Iftheproviderdoesnothaveanaccuratepersonalorfamilyhistorytodetermine whichgenetictest(s)areimplicated,theincorrectorincompletetest(s)maybeordered. • LaboratoryProcessing:Alllaboratoriesmustmeettheproperrequirementstoprocessyoursampleandstrict guidelinesmaybeinplacetoensuretheserequirements;however,inrarecases,problemsmayoccurinhandling thesample,whichmightleadtoincorrectresults. • ImplicationsofResults:Thegenetictestmayrevealanalterationinageneorseveralgenesbuttheremaybelimits towhatisknownabouteachgeneandthesignificanceoftheresultmaybeuncertain.Ageneticalterationor variationcannotdeterminewhetheryouwillactuallydevelopasuspectedcondition,thetimingofitsdevelopment ortheseverityofthecondition. Itisimportantthatyoudiscussyourgenetictestresultwithyourprovidersothatyoucanmakeaninformeddecision aboutyournextsteps. Whatarethebenefitsofgenetictesting? Thereareseveralbenefitstoperforminggenetictesting.Ifageneticvariationisdetermined, • Theremaybepreventivemeasuresoridentifiedmedicaltreatmentsthatdecreaseyourchancesofdevelopinga relatedgeneticsyndrome,diseaseordefect. • Theknowledgecanempowerapersontomakeimportantchoicesaboutlifeplanning,evenifacureisnotavailable atthetimeoftesting. • Apersonmayqualifytoenrollinarelatedresearchstudy,whichmayleadtonewtreatments. • Itmayprovideimportanthealthinformationforaperson’sfamily. CLIA#11D2084528 11535ParkWoodsCircle,SuiteE;Alpharetta,GA30005 1-855-647-4363 www.mygenomics.com MGV101/REV 09-16 Whataretherisksofgenetictesting? Therearepossiblerisksofgenetictesting: • Althoughlowrisk,theremaybeaphysicalriskinvolvedinobtainingthesamplefortesting. • Therearepotentialpsychologicalandsocialrisksoftestingbecausetheycanchangeaperson’slifeperspective.It maybestressfulandtheremaybeanemotionalreactiontolearningaboutrisksforyourselforyourfamily.Thisis whyitisimportanttodiscussthetestingwithyourprovideroraGeneticCounselorbeforetesting. • Therearepossibleeconomicrisksofgenetictestingthatmayinterferewithapatient’sabilitytoobtainhealth,life, disabilityorlong-termcareinsurance. • Thegenetictestresultswillbecomeapartofyourmedicalrecord.Ifagenetictestisperformed,yourinsurance companymayhaveaccesstotheresult. • Therearebothstateandfederallawsthatweredevelopedtohelpprotectapersonfromgeneticdiscrimination, whichisthemisuseofgeneticinformation.GINAistheGeneticInformationNondiscriminationActof2008andisa federallawthatprotectsindividualsfromgeneticdiscriminationinhealthinsuranceandemployment. WhatcanIlearnfrommygenetictestresult? Resultscanbeclassifiedasnegativeorpositive. • Anegativeor“normal”resultmeansthetestdidnotdetectavariationorchangeinthegene(s)tested.Thismayhave limitationsinthatallgenesrelatedtoaparticularconditionmaynothavebeentested.Therefore,anegativetest doesnotalwaysruleoutthedevelopmentofaproblematicgeneticcondition.Also,technologyimproveseveryyear andtheremaybenewdiscoveriesthatareassociatedwithaparticulargeneticconditionthatwasunknownatthe timeoftesting. • Apositiveor“abnormal”resultmeansthatyouhaveageneticchangeorvariationthatisrelatedtothedevelopment ofaspecificgeneticconditionthatmayputyouatanincreasedrisk.However,notallgenevariationsleadto symptomsorthedevelopmentofthegeneticcondition. • Aninconclusiveresultmeansthatitmayfallbetweena“normal”or“abnormal”rangeorbe“indeterminate.”Insuch cases,thismaybelabeledasaVUSorvariantofunknownsignificance.Eventhoughachangeinthegenemaybe detected,thelaboratorymaynothaveenoughinformationtodetermineifthegeneplacesapersonatanincreased risk.Laboratoriesmaylearnmoreaboutthatvariantinthefutureandbeabletomakeamoredefinitivedecision aboutthesignificanceofthegenevariation. • Inrarecases,agenetictestmayrevealanimportantgeneticvariationthatisnotdirectlyrelatedtothereasona providerorderedthetest.Theseresultsarecalledsecondaryorincidentalfindings.Examplesmayinclude: - Non-paternity:Thepersondesignatedasthefatherisnotthebiologicalfatherofthepersonhavingtesting. - Consanguinity:Thebiologicalparentsarecloselyrelatedbyblood. - Identificationofaconditionunrelatedtothereasonfortesting Resultinterpretationisbasedoncurrentandavailableinformationpresentinmedicalliterature,researchandscientific databases.Becausetheseresourcesareconstantlychanging,newinformationthatbecomesavailableinthefuturemayreplace oraddtotheinformationmyGenomicsusedtointerpretaperson’stestresults.myGenomicsdoesnotroutinelyre-analyze testresultsthathavealreadybeenissuedandhasnoobligationtodoso.Apersonmaymonitorpubliclyavailableresources suchasClinVar(www.clinvar.com)tolearnaboutcurrentinformationabouttheclinicalinterpretationofagenetictest. Whathappenstomysampleaftertesting? DNAsamplesarenotreturnedtoapersonafterthetesthasresulted.De-identifiedsamplesandde-identifiedtestresults maybestoredinarepositoryandusedforinternalvalidation,educational,researchpurposesincludingHIPAA-compliant databasesorpresentedinscientificpresentationsorpapers. Researchwithde-identifiedsamplesandtestdatathatresultsinmedicaladvancesmayhavepotentialcommercialvalueand maybedevelopedandownedbymyGenomicsortheresearcherswhoanalyzethedata.Ifanyindividualorcorporation benefitsfinanciallyfromstudyingaperson’sde-identifiedgeneticmaterial,nocompensationwillbeprovidedtotheperson orperson’sheirs. myGenomicshasnoobligationtoretainaperson’ssampleindefinitelyandmaydestroyitonceitnolongerhasalegalduty toretainit.Byconsentingtothisagreement,IprovideauthorizationformyGenomicsanditspartnerstousemyormychild’s de-identifiedsampleandtestresultsforsuchpurposesasmentionedabove. Unlessoptedoutonthefirstpageoftherequisition,myGenomicsmaycontactmeinthefutureregardingtheopportunityto participateinresearchopportunities,includinganyavailabletreatmentformyselfand/ormyfamily. CLIA#11D2084528 11535ParkWoodsCircle,SuiteE;Alpharetta,GA30005 1-855-647-4363 www.mygenomics.com MGV101/REV 09-16 ☐ IunderstandthatImaycontactmyGenomicsviaemailatinfo@mygenomics.comorbyphoneat1-855-647-4363ifIwish tooptoutoffuturecontactorhaveanyquestionsrelatedtomytestresults. ☐ IunderstandthatsamplesfromresidentsofNewYorkStatewillnotbeincludedinthede-identifiedresearchstudiesdescribedinthis authorizationandwillnotberetainedformorethan60daysaftertestcompletion,unlessspecificallyauthorizedbymyselectionbelow. TheauthorizationisoptionalandtestingwillnotbeaffectedifIdonotchecktheboxfortheNewYorkauthorizationlanguage. ☐ InternationalSpecimens:IfmychildorIresideoutsideoftheUnitedStates,Iattestthatbyprovidingasamplefortesting, Iamnotknowinglyviolatinganyexportbanorotherlegalrestrictioninthecountryofmyormychild’sresidence. ☐ PatientConfidentialityandGeneticCounseling:ItisrecommendedthatmychildorIreceivegeneticcounselingbeforeandafterthe genetictest.Furthertestingorconsultationswithahealthcareprovidermaystillbenecessary.Tomaintainconfidentiality,thetestresults willonlybereleasedtothereferringhealthcareprovider,totheorderinglaboratory,tomeorotherhealthcareprovidersinvolvedinmy ormychild’sdiagnosisandtreatment,ortoothersasentitledbylaw.TheUnitedStatesFederalGovernmenthasenactedseverallawsthat prohibitdiscriminationbasedongenetictestresultsbyhealthinsurancecompaniesandemployers.Inaddition,theselawsprohibit unauthorizeddisclosureofthisinformation.Formoreinformation,IunderstandthatIcanvisitwww.genome.gov/10002077. PatientAcknowledgement:Byagreeingtothisauthorization,Iacknowledgethefollowing: • • • • • • • • • • • • • • Iameither(1)thepatientprovidingthesampleandamatleast18yearsofageor(2)Ihavelegalauthorizationtoprovidethisinformed consentonbehalfofanotherperson. Ihavereadandagreetothecontentsofthisform. Iunderstandthebenefits,risksandlimitationsofgenetictesting. Irecognizetheseriousnessofconditionsforwhichtestingisbeingordered,andthatdiseasedescriptions,prognoses,andtreatment optionshavebeenmadeavailabletomebymyormychild’shealthcareprovider. Ihavebeeninformedoftheavailabilityofgeneticcounselingservices.Icanfindageneticcounselorinmyareaat:www.nsgc.org. Iwillbegiventheopportunitytodiscusstheresultsofthetestwithmyhealthcareprovider,onceIreceivethem. Iamresponsibleforinformingmyorderinghealthcareproviderofchangesinmyormychild’sfamilyhistory. IunderstandthatmyGenomicsmaycontactmeinthefutureforresearchopportunities,includingtreatmentsfortheconditioninwhich myormychild’sfamily.(PleasechecktheboxattheendofthisAuthorizationifyouwishtooptoutoffutureresearchopportunities.) IunderstandthatmyGenomicsmayusemyormychild’sde-identifiedinformationandtestresultsforvalidation,educationaland/or researchpurposes,andthisde-identifieddatamaybesubmittedinaHIPAA-compliantmannertoresearchdatabases. Fortestsorstudiesthatgeneratedatafrommultiplefamilymembersormyspouseorpartner,Iconsenttoallofthedatabeingincluded inasinglecomprehensivereportthatwillbesharedwithparticipatingfamilymembers,myspouseorpartner. IfmyGenomicsoracontractedpartnerofmyGenomics(collectively,“myGenomicsPartners”)isbillingmymedicalinsurancecarrier directly,IrepresentthatIamcoveredbyinsuranceandauthorizemyGenomicsPartnerstogivemydesignatedinsurancecarrier,health plan,orthirdpartyadministrator(collectively,“Plan”)theinformationonthisformandotherinformationprovidedbymyhealthcare providernecessaryforreimbursement,andIauthorizePlanbenefitstobepayabledirectlytomyGenomicsPartners. IauthorizemyGenomicsPartnerstoinformmyPlanofmytestresult(s)onlyifthetestresult(s)arerequiredforpreauthorizationof,or paymentfor,additionaltesting. IwillcooperatefullywithmyGenomicsPartnersbyprovidingallnecessarydocumentsneededforinsurancebillingandappeals;and understandthatIamresponsibleforsendingmyGenomicsPartnersany,andall,ofthemoneythatIreceivedirectlyfrommyinsurance companyinpaymentforthethistest.Reasonablecollectionand/orattorney’sfees,includingfilingandservicefees,shallbeassessedif theaccountissenttocollection,aspermittedbystatelaw.Ipermitacopyofthisauthorizationtobeusedinplaceoftheoriginal. Finally,ifIhavethelegalauthorizationtoprovidethisinformedconsentonbehalfofanotherperson,Iamattestingthatthesample providedbelongstothatperson. Patient/GuardianAuthorization Bymysignaturebelow,Iattestthefollowing: IhavereadandIunderstandtheinformationprovidedonthisform. OptOutforResearchandContact ☐ Idonotwishtoparticipateinanyresearchstudies. ☐ IdonotwishtobecontractedbymyGenomicsforfutureresearchopportunities.Iunderstandthatmyelectiontooptoutofsuchfollow upcontactswillnotaffectmyabilitytoobtaintesting. AuthorizationofNewYorkResidents ☐ IamaNewYorkstateresidentandIgivepermissionformyGenomicstoretainanyremainingsamplelongerthan60daysafter completionoftestingandusemyde-identifieddataforscientificandmedicalresearchpurposes.Suchauthorizationisoptionalandisnot requiredfortesting. Patient/GuardianName:__________________________________________________________________________________________________________________________ FirstName MiddleName LastName DateofBirth:mm/dd/yyyy Patient/GuardianSignature:__________________________________________________________________________________ Date:______________________________ mm/dd/yyyy HealthCareProvider’sStatement Thistestismedicallynecessaryfortheriskassessment,diagnosisordetectionofadisease,illness,impairment,symptom,syndromeordisorder. Theresultswilldeterminemypatient’smedicalmanagementandtreatmentdecisions.Bymysignaturebelow,IindicatethatIamthereferring physicianorauthorizedhealthcareprovider.Ihaveexplainedthepurposeofthetestdescribedabove.Thepatienthasbeengiventheopportunity toaskquestionsand/orseekgeneticcounseling.ThepatienthasvoluntarilydecidedtohavethetestperformedbymyGenomics. HealthCareProvider’sSignature_____________________________________________________________________________ Date:______________________________ mm/dd/yyyy CLIA#11D2084528 11535ParkWoodsCircle,SuiteE;Alpharetta,GA30005 1-855-647-4363 www.mygenomics.com MGV101/REV 09-16